These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7842090)

  • 1. [Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    David M; Sempé M; Blanc M; Nicolino M; Forest MG; Morel Y
    Arch Pediatr; 1994 Apr; 1(4):363-7. PubMed ID: 7842090
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
    La Selve H; Sempé M; Morel Y; Forest MG; de Peretti E; David M
    Arch Fr Pediatr; 1985; 42(7):511-6. PubMed ID: 2935112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patterns of growth in congenital adrenal hyperplasia. Correlation between glucocorticoid therapy and stature].
    Igea JM; Lóridan L; Martul P; Ferrández A; Mayayo E; Rodríguez M; Oyarzábal M; Elcarte R; Luzuriaga C
    An Esp Pediatr; 1988 Oct; 29 Suppl 35():9-12. PubMed ID: 3272842
    [No Abstract]   [Full Text] [Related]  

  • 4. [Congenital adrenal hyperplasia by deficiency of 11 beta hydroxylase].
    Slimane H; Kraiem S; Boukhris R; Ben Khalifa F
    Tunis Med; 1992 Feb; 70(2):97-101. PubMed ID: 1496742
    [No Abstract]   [Full Text] [Related]  

  • 5. [11beta-hydroxylase deficiency: improvement of final height with growth hormone and gonadotropin-releasing hormone analog].
    Orío Hernández M; Yebra Yebra J; Bezanilla López C; Gracia Bouthelier R
    An Pediatr (Barc); 2007 Aug; 67(2):153-6. PubMed ID: 17692261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Back to basics: early diagnosis and compliance improve final height outcome in congenital adrenal hyperplasia.
    Schwartz RP
    J Pediatr; 2001 Jan; 138(1):3-5. PubMed ID: 11148504
    [No Abstract]   [Full Text] [Related]  

  • 7. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis.
    Eugster EA; Dimeglio LA; Wright JC; Freidenberg GR; Seshadri R; Pescovitz OH
    J Pediatr; 2001 Jan; 138(1):26-32. PubMed ID: 11148508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method.
    Bonfig W; Schwarz HP
    J Pediatr Endocrinol Metab; 2012; 25(7-8):645-9. PubMed ID: 23155688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the dose of oral hydrocortisone on growth rate during long-term treatment of children with salt losing congenital adrenal hyperplasia.
    Ciaccio M; Montiveros C; Rivarola MA; Belgorosky A
    Medicina (B Aires); 2002; 62(6):551-4. PubMed ID: 12532689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth pattern and final height in 21-hydroxylase deficiency.
    Bajpai A; Pandey RM; Kabra M; Menon PS
    Indian Pediatr; 2007 Oct; 44(10):771-3. PubMed ID: 17998577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth and puberal development in males with adreno-genital syndrome].
    Gargantini L; Calzi P; Brunelli V; Braggion F; Chiumello G
    Pediatr Med Chir; 1989; 11(6):597-602. PubMed ID: 2699925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital adrenogenital syndrome due to 21-hydroxylase deficiency. Pathogenesis, clinical picture, and deliberations over better therapy].
    von Schnakenburg K
    Med Welt; 1977 Sep; 28(36):1415-22. PubMed ID: 904447
    [No Abstract]   [Full Text] [Related]  

  • 13. Audit of care of patients with congenital adrenal hyperplasia due to 21-Hydroxylase deficiency in a referral hospital in South India.
    Bhaskaran S; Nair V; Kumar H; Jayakumar RV
    Indian Pediatr; 2006 May; 43(5):419-23. PubMed ID: 16735765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital virilizing adrenal hyperplasia due to 11 -beta-hydroxylase deficiency. Study of 11 cases (author's transl)].
    Dunand A; Roger M; Chaussain JL; Nocton F; Job JC
    Ann Pediatr (Paris); 1981 Mar; 28(3):179-84. PubMed ID: 7224566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes of statural and osseous growth after medical or surgical therapy in adrenal diseases in childhood].
    Ferrante L
    Minerva Pediatr; 1967 Apr; 19(15):711-4. PubMed ID: 4302097
    [No Abstract]   [Full Text] [Related]  

  • 16. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
    Hoepffner W; Kaufhold A; Willgerodt H; Keller E
    Horm Res; 2008; 70(1):42-50. PubMed ID: 18493149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal salt loss in the hypertensive form of congenital adrenal hyperplasia.
    Holcombe JH; Keenan BS; Nichols BL; Kirkland RT; Clayton GW
    Pediatrics; 1980 Apr; 65(4):777-81. PubMed ID: 6966049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term steroid therapy in patients with adrenogenital syndrome.
    Riddick DH; Hammond CB
    Obstet Gynecol; 1975 Jan; 45(1):15-20. PubMed ID: 163015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hydrocortisone on adult height in congenital adrenal hyperplasia-the Minnesota cohort.
    Sarafoglou K; Addo OY; Turcotte L; Otten N; Wickremasinghe A; Pittock S; Kyllo J; Lteif AN; Himes JH; Miller BS
    J Pediatr; 2014 May; 164(5):1141-1146.e1. PubMed ID: 24560184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.